Next |
home / stock / fldm / fldm message board
Subject | By | Source | When |
---|---|---|---|
$FLDM bot this 30 min chart today.. | manysevens | investorshub | 11/25/2021 2:35:03 AM |
No. I think they are in deep doo | Eggplant | investorshub | 11/08/2021 10:36:44 PM |
$FLDM Back from the dead? | LongTimeObserver | investorshub | 11/06/2020 7:08:34 PM |
Pffft! $FLDM | LongTimeObserver | investorshub | 10/29/2020 4:02:59 PM |
06:28 $FLDM Fluidigm: Trump Administration provides saliva test at surge | Atlanta1 | investorshub | 10/19/2020 12:27:10 PM |
Dont want to jinx it, but currently the | Ckasper | investorshub | 09/15/2020 8:17:48 PM |
Does anybody know, when they are expecting the | Ckasper | investorshub | 09/14/2020 6:43:54 PM |
The retarded Newscum of Khalifhurnia should do the | lakingsphan0427 | investorshub | 09/11/2020 3:18:29 PM |
Fluidigm Corporation (Nasdaq: $FLDM), an innovative biotechnology tools | Hole shot King | investorshub | 09/08/2020 1:29:08 PM |
8K Item 8.01. Other Events. | Hole shot King | investorshub | 09/08/2020 1:27:45 PM |
NEWS OUT. $FLDM fulfills first step of NHI requirements. | Ckasper | investorshub | 09/08/2020 1:11:09 PM |
The Law Offices of Frank R. Cruz Announces | Hole shot King | investorshub | 09/05/2020 1:09:12 AM |
$FLDM should have a good bounce | Hole shot King | investorshub | 09/04/2020 2:11:27 PM |
Keep it coming. Gotta be patient | Ckasper | investorshub | 09/04/2020 1:26:30 PM |
$FLDM Gov of Missouri is working in the | Hole shot King | investorshub | 09/03/2020 6:41:44 PM |
$FLDM Governor to talk saliva-based COVID-19 test https://www.newspressnow.com/n | Hole shot King | investorshub | 09/03/2020 5:21:58 PM |
Quick testing is still highly demanded. Especially with | Ckasper | investorshub | 09/02/2020 3:18:31 PM |
Not sure it might be over its all | jonsmile | investorshub | 09/02/2020 3:17:11 PM |
Agree. Thats why Im saying its going up | Ckasper | investorshub | 09/02/2020 3:15:53 PM |
This entire sector has been down $OPK as well | jonsmile | investorshub | 09/02/2020 3:14:55 PM |
News, Short Squeeze, Breakout and More Instantly...
Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025 Delivered pro forma combined revenue of $46.2 million, gross margin of 49.2%, non-GAAP gross margin of 56.3%, operating expense reduction of app...
Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025 Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on May 8, 2024 conference call SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLO...
SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the m...